| Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery. | |
| | |
MedLine Citation:
|
PMID: 20133462 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
CONTEXT: Severe hypoglycemia after Roux-en-Y gastric bypass surgery (RYGB) is an increasingly recognized condition, characterized by neuroglycopenia and inappropriately elevated insulin concentrations that occur primarily in the postprandial state. Both pathophysiology and treatment of this disorder remain elusive, but it has been postulated that hyperplasia and/or hypertrophy of beta-cells due to morbid obesity and/or postsurgical nesidioblastosis may contribute. OBJECTIVE: The objective of this study was to elucidate the pathophysiology of this condition; specifically, we hypothesized that metabolic abnormalities were a function of altered nutrient transit through the gastrointestinal tract rather than anatomical changes to pancreatic beta-cells that would lead to consistently high insulin secretion irrespective of nutrient transit route. DESIGN/SETTING/SUBJECT/OUTCOME MEASURES: We describe a unique case wherein gastrostomy tube (GT) insertion into the remnant stomach reversed neuroglycopenic symptoms. This subject was admitted to a university hospital research center for standardized measurement of glucose, insulin, and incretin hormones including glucagon-like peptide-1, gastric-inhibitory peptide, and glucagon. RESULTS: Standardized liquid meal administration via GT vs. oral route demonstrated complete reversal of severe metabolic abnormalities that included hypersecretion of insulin and GLP-1. CONCLUSION: Post-RYGB hyperinsulinemia and hypoglycemia result entirely from altered nutrient delivery rather than generalized hyperfunction of beta-cells due to presurgical hypertrophy/hyperfunction or postsurgical nesidioblastosis. These findings support the use of GT for treatment of severe cases and have implications for surgical manipulations that may reverse/prevent this condition. |
| | |
Authors:
|
Tracey McLaughlin; Marcia Peck; Jens Holst; Carolyn Deacon |
Publication Detail:
|
Type: Case Reports; Journal Article Date: 2010-02-04 |
Journal Detail:
|
Title: The Journal of clinical endocrinology and metabolism Volume: 95 ISSN: 1945-7197 ISO Abbreviation: J. Clin. Endocrinol. Metab. Publication Date: 2010 Apr |
Date Detail:
|
Created Date: 2010-04-08 Completed Date: 2010-04-30 Revised Date: 2010-06-16 |
Medline Journal Info:
|
Nlm Unique ID: 0375362 Medline TA: J Clin Endocrinol Metab Country: United States |
Other Details:
|
Languages: eng Pagination: 1851-5 Citation Subset: AIM; IM |
Affiliation:
|
Stanford University School of Medicine, Department of Medicine, Division of Endocrinology, Stanford, California 94305-5103, USA. tmclaugh@stanford.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Blood Glucose / metabolism Body Mass Index Female Gastric Bypass / adverse effects* Gastric Inhibitory Polypeptide / blood Glucagon / blood Glucagon-Like Peptide 1 / blood Humans Hyperinsulinism / etiology* Hypoglycemia / etiology* Insulin / blood Nutritional Status Obesity, Morbid / therapy Postoperative Complications / blood, metabolism* |
| Chemical | |
Reg. No./Substance:
|
0/Blood Glucose; 11061-68-0/Insulin; 59392-49-3/Gastric Inhibitory Polypeptide; 89750-14-1/Glucagon-Like Peptide 1; 9007-92-5/Glucagon |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Tetraiodothyroacetic Acid (Tetrac) and Nanoparticulate Tetrac Arrest Growth of Medullary Carcinoma o...
Next Document: Sex Hormone-Binding Globulin as an Independent Determinant of Cortical Bone Status in Men at the Age...